ClinicalTrials.Veeva

Menu

Clinical Study of the Effects of a SWalker II and VR for Hip Fracture Rehabilitation in the Elderly (SWalker-VR)

W

Werium Assistive Solutions

Status

Invitation-only

Conditions

Hip Fractures
Gait Disorders in Old Age

Treatments

Other: Phase I - Early gait rehabilitation
Other: Preliminary Phase
Other: Phase II - Maintenance gait function ( with VR)

Study type

Interventional

Funder types

Industry

Identifiers

NCT06025981
SWalker-II-VR

Details and patient eligibility

About

This project is structured in two distinct phases. The first phase deals with the recovery of the hip fracture in the acute phase up to ambulation, and the second is understood as the continuation of functional improvement of gait. In the first phase, the aim is to evaluate the effects of the use of the robotic device (SWalker) on the physical improvement of the patient. While in the second phase, the objective is to evaluate the effects of virtual reality technology combined with the use of the SWalker.Therefore, the following specific objectives are identified:

  • Phase I: To analyze the effects of SWalker application in patients with acute hip fracture on clinical parameters of rehabilitation.
  • Phase II: To study the effects of the application of the SWalker combined with immersive technology in people with impaired gait function after hip fracture.

Full description

In the preliminary phase, the usability and acceptance of the SWalker II system combined with virtual reality is evaluated with a group of healthy subjects. For this purpose, an exposure session and the evaluation of the system based on questionnaires are carried out. On the other hand, a gait characterization session (capture of ROM and EMG) is performed inside and outside the walker with different speeds and weight loads.

In the first phase of the clinical study, patients with hip fractures in the early rehabilitation phase were recruited. They are randomly assigned to a control group or experiment group. And for a period of 6 weeks, both groups carry out the same rehabilitation exercise program based on strength, balance and ambulation exercise. The difference is that the experimental group performs the rehabilitation exercises with the SWalker, and the control group performs these exercises with conventional parallel bars.

In the second phase of the clinical study, these same patients who have passed the first pass, move on to a 6-weeks program of maintenance and improvement of gait function. Again, they are divided into 2 groups, control and experimental. So the control group will perform walking exercises with the Swalker and conventional balance exercises and the experimental group will perform walking and balance exercises with SWalker and virtual reality.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants of both sexes over 65 years of age,
  • Patients with a height of less than 180 cm,
  • Patients weighing less than 90 kg,
  • Patients who have suffered a hip fracture* and wish to participate in the study.
  • In addition, they must sign and understand the informed consent form.

Exclusion criteria

  • Cognitive status insufficient to understand and execute instructions given by the physiotherapist.

    • Patients needing rehabilitation after hip fracture may vary from a few days to a few weeks after the period of occurrence of the hip fracture, depending on the complications that could arise and the type of surgery used, with a pre-set limit of one month.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

100 participants in 2 patient groups

Preliminary Phase
Other group
Description:
20 healthy subjects will perform an experimental session for characterization of functional status with clinical scales; characterization of gait with SWalker using ROM and EMG at different speeds and weight bearing; and assessment of system usability with VR using standardized questionnaires.
Treatment:
Other: Preliminary Phase
Phase I and II
Other group
Description:
In both phases 100 subjects will perform a gait rehabilitation intervention program (phase 1) and maintenance (phase 2), in which they will employ the use of the robotic walker and virtual reality depending on the group and phase. The evolution of functional clinical parameters will be studied for both groups and phases.
Treatment:
Other: Phase II - Maintenance gait function ( with VR)
Other: Phase I - Early gait rehabilitation

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems